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Abstract
Background: Eccrine carcinoma is a quite rare malignant tumor that typically arises from a normal
sweat gland and that features a rather high recurrence rate subsequent to simple excision. Given
its rather poor response to adjuvant therapy, wide excision of the lesion with tumor-free margins
may offer a reasonable chance for long-term control of this neoplasm.
Case presentation: Herein, we report on an unusual case of perianal eccrine carcinoma, initially
presenting as a perianal abscess.
Conclusion:  Even though eccrine carcinomas would appear to be rare, when dealing with
recurrent skin tumors or recurrent perianal fistulas, the possibility of eccrine carcinoma should be
considered by consulting clinicians.
Background
There are three types of sweat glands that occur over the
skin surface: eccrine, apocrine and apoeccrine. Eccrine
sweat glands are one of the major sweat glands found in
humans. Such sweat glands are distributed over the entire
body skin surface, with the greatest density being found
on the palms of the hands and soles of the feet [1]. Eccrine
sweat glands are innervated by postganglionic sympa-
thetic fibers, and their major function is thermoregulation
via evaporative heat loss and electrolyte balance [1]. The
majority of perianal sweat glands are of the apocrine type
[1].
Eccrine carcinoma is a rare, malignant sweat gland tumor,
generally featuring a slow growth rate and a rather high
local recurrence rate [2]. Sweat gland carcinomas were first
reported by Stout and Cooley in 1951 with the observa-
tion that, "sweat gland carcinoma often developed at the
site of pre-existing nodules of longstanding and they have
a propensity to metastasize" [2]. The first large study per-
taining to the classification of sweat gland carcinomas was
published in 1968 by Berg and McDivitt [3]. More recent
attempts at classification of such carcinomas would
appear to provide somewhat different results, with the rel-
ative appropriateness of such classification schemes
remaining quite controversial at the time of writing [1].
Appropriate sweat gland carcinoma classification is clearly
important since each of the specific sweat gland carcino-
mas features its own characteristic biological behavior [4].
Thus, appropriate classification of such sweat glands, and
associated tumors, enables us to devise a specific and
appropriate sweat gland tumor therapeutical plan, and
also an associated precise prognosis, i.e. apocrine carcino-
mas are able to metastasize to regional lymph nodes and
do so frequently, whereas eccrine carcinomas are typically
not able to metastasize [4]. The incidence of sweat gland
carcinoma appears to be female predominant and usually
involves individuals of middle to old age [5]. Such a
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tumor is able to develop anywhere on the trunk of the
body or on the extremities, even the eyelid [6] and nipple-
areolar complex [7]. Unfortunately, as far as we are aware,
sweat gland carcinomas are often under diagnosed or mis-
diagnosed due to their clinical rarity [8]. The clinical man-
ifestation of eccrine carcinoma is destructive with a
propensity for local recurrence [4,8]. Lymph node
involvement is typically rare for eccrine carcinoma but
distal metastasis is not uncommon [4].
Case presentation
A-57-year-old female patient presented at our institution
with an apparently slow growing and painful perianal
mass, which had produced some serous discharge for the
preceding several years. The woman denied any history of
constipation or anal bleeding, and she also denied any
history of major disease including malignancy. Digital
examination revealed a huge (5 × 5 × 5 cm), well-defined
solid tumor associated with a skin ulcer, which was
located over the left posterior region of the buttock adja-
cent to the anus. Tracing back her surgical history, this
patient had undergone perianal skin tumor excision twice
previously, once in 1981 and again in 1992. On both
occasions, this was due to the presence of a painful peri-
anal mass.
According to her description of the previous perianal
masses, they were firm and slow growing, and featured
associated skin ulceration (Figure 1A). The pathology
report for the mass removed in 1992 at our hospital stated
it was a 5 × 5 × 3 cm perianal syringocystadenoma papil-
liferum. During the surgical procedure conducted in
1992, the surgical wound was repaired with a rotation
skin flap as there was a rather large skin defect. She was
free of disease between the two surgeries for about 8 years.
Laboratory data, including complete blood count and rel-
evant blood biochemistry, were unremarkable. Under the
initial impression of a perianal fistula or perianal skin
tumor, incision biopsy was performed. The biopsy speci-
men was sent for frozen section examination, which
revealed malignant neoplasm with myoepithelial-like
proliferation. Following this histopathology report, en-
bloc excision was undertaken in order to excise the tumor
Clinicla photograph 1a) The perianal mass prior to excision was firm and revealed skin ulceration Figure 1
Clinicla photograph 1a) The perianal mass prior to excision was firm and revealed skin ulceration. 1b) The wound following en-
bloc excision of the tumor. 1c) The excised specimen measured 7 × 6.5 × 5 cm and revealed a previous biopsy cavity. On serial 
sectioning, the tumor appeared well-defined, firm and gray-to-white in color.World Journal of Surgical Oncology 2007, 5:100 http://www.wjso.com/content/5/1/100
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with a gross margin of 2 cm (Figure 1B). The post-surgery
wound was left to heal openly without resorting to flap
closure (Figure 1C).
Subsequent to surgery, metastatic work-ups revealed mul-
tiple nodules over both of the patient's lungs, presumably
secondary to the primary malignant neoplasm. Other
examinations, including immunological tumor markers
(CA 19-9: 16.5; CEA: 0.2; CA 125: 15.4; SCC: 0.2), spu-
tum cytology and gynecological ultrasonography, were
performed and all produced unremarkable results. The
final pathology report suggested the presence of an eccrine
adenocarcinoma. Microscopically, lesion sections
revealed hyperchromatic neoplastic cells arranged in solid
nests, anastomosing trabeculae with ductular formation
(Figure 2A), a syringoid tubular or cord-like pattern, and
irregular cribriform glandular structures (revealing an ade-
noid cystic carcinoma-like pattern) with irregular infiltra-
tive tumor margins (Figure 2B).
The tumor cells were characterized by the presence of mild
to moderate nuclear pleomorphisms, occasional distinct
nucleoli, not uncommon mitotic activity, and a variable
amount of eosinophilic, basophilic or clear cytoplasm fea-
turing focal tumor necrosis. Perineural invasion and lym-
phovascular space permeation were also noted (Figure
2C). Immunohistochemically, the proliferated stromal
cells and peripheral cells of the tumor nest or glandular
structures were focally positive for SMA. The luminal
tumor cells and central cells of the tumor nests were vari-
ably positive for polyclonal CEA and CK7. All of the neo-
plastic cells were negative for EMA, CDX2 and TTF-1, and
no evident tumor cell mucin production was seen on
mucicarmine and DPAS staining. The cancer invaded the
dermis and subcutis. The epidermis was spared and free of
pagetoid involvement.
Discussion
Surgery is the first choice for management of such eccrine
carcinomas since this type of carcinoma typically features
a poor response to chemotherapy and/or radiotherapy
[9]. However, it has been reported that one patient with
distal metastasis secondary to an eccrine tumor responded
well to tamoxifen [10]. Wide, deep surgical excision of the
tumor, with verification of tumor-free margins, should
offer a reasonable chance of long-term control of eccrine
carcinoma [10]. The use of Mohs micrographic surgery
was proposed by Wildemore et al. recently in order to
attempt to decrease the recurrence rate of this type of
tumor when compared to conventional surgical excision
practices [11]. However, longer follow-up intervals are
reportedly necessary.
For our patient, when dealing with the current tumor, we
intended to review the histopathology slides prepared in
1992 from the patient's previous episode in order to com-
pare presentations and determine whether any mistake
may have been made previously regards microscopic
interpretation of the prepared tissue slides.
Unfortunately, the relevant slides had been lost during
transportation several years previously and we were
denied such an opportunity. Following our review of the
literature, as far as we were able to determine, there is one
case report about a patient whose eccrine porocarcinoma
could possibly have arisen from a long-standing benign
eccrine poroma [13]. Otherwise, no evidence suggesting
the transformation of a benign eccrine tumor to a malig-
nant lesion has ever been found.
As for the suspicious nodules present on this patient's
chest X-ray, we suggested thoracoscopic biopsy as being
appropriate and, subsequent to metastasis having been
photomicrograph: 2A)Microscopic examination revealed hyperchromatic neoplastic cells arranged in solid nests, and anasto- mosing trabeculae with ductal formation Figure 2
photomicrograph: 2A)Microscopic examination revealed hyperchromatic neoplastic cells arranged in solid nests, and anasto-
mosing trabeculae with ductal formation. (H&E × 200) 2B) Microscopic examination also revealed irregular cribriform glandu-
lar structures (featuring an adenoid cystic carcinoma-like pattern) with irregular infiltrative tumor margins. (H&E × 200) 2C) 
Perineural invasion and lymphovascular space permeation were noted upon microscopic examination. (H&E × 200).Publish with BioMed Central    and   every 
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confirmed, concurrent chemo-radiotherapy. However,
this was refused by the patient.
Conclusion
Even though eccrine carcinoma is a clinical rarity, when
dealing with recurrent skin tumors or recurrent perianal
fistulas, the possibility of eccrine carcinoma should be
considered by consulting clinicians. Such a tumor can be
slow growing but does feature the potential for recurrence,
as well as distal metastasis [12]. A high index of suspicion
and the taking of perisurgical frozen sections will likely
elicit a greater diagnostic rate for this malady, and initial
wide excision of the tumor with adequate margins should
thus significantly reduce the likelihood of a secondary
perianal procedure being necessary. Distal metastasis
work-up should be performed routinely for patients
afflicted with eccrine carcinoma. Although prognosis for
eccrine carcinoma is somewhat guarded, repeated wide
excision of the primary lesion may be necessary
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